Related Experiment Video
Updated: Sep 9, 2025

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.2K
Innovative Training to Improve Childhood Cancer Knowledge Among Primary Health Care Providers: Evaluating a Blended
Larissa Klootwijk1,2, Lilian Apadet Osamong3, Ibrahim El Salih1,2
1Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
JCO Global Oncology
|September 3, 2025
Summary
A blended learning program improved childhood cancer knowledge for health care providers, but this knowledge faded over six months. Despite increased case suspicion, referral rates did not improve, indicating persistent barriers.
Area of Science:
- Pediatric Oncology
- Global Health
- Health Professions Education
Background:
- Early detection of childhood cancer is crucial for improving outcomes in low- and middle-income countries.
- Training primary health care providers (HCPs) in resource-limited settings presents significant challenges due to time and resource constraints.
Purpose of the Study:
- To assess the knowledge of primary health care workers regarding childhood cancer following a blended learning program.
- To evaluate the impact of this training on the referral of suspected childhood cancer cases.
Main Methods:
- A prospective study in Bungoma, Kenya, evaluated a blended pediatric oncology training program.
- Knowledge was assessed using a semistructured questionnaire at baseline, immediately post-training, and six months later.
- Referral data from the region were analyzed before and after the training intervention.
Main Results:
- A total of 496 (16%) of 3,040 participants completed the program. Median knowledge scores significantly increased post-training but declined significantly after six months.
- Community health volunteers consistently scored lower than other HCPs across all assessment points.
- Despite 36% of participants reporting suspecting childhood cancer cases, the average annual referrals remained unchanged (14 cases).
Conclusions:
- The blended learning program initially enhanced knowledge but showed a significant decline after six months.
- While digital learning components show potential, low referral rates underscore the need to address systemic barriers to effective patient referral.
- Further strategies are needed to sustain knowledge and improve referral pathways for childhood cancer.
Related Concept Videos
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Primary Healthcare Services
1.5K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.5K
Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K

